{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:49:58Z","timestamp":1769932198601,"version":"3.49.0"},"reference-count":13,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2024,12,23]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Valve-related haemolysis is a known complication following prosthetic valve surgery. Haemolysis after transcatheter aortic valve implantation (TAVI) has been reported in some studies, all of which were non-critical. Data related to haemolysis associated with new-generation balloon-expandable valve (BEV) are scarce.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Among 441 patients who underwent TAVI between April 2023 and June 2024, 282 patients treated with new-generation BEV were analysed. Haemolysis was defined based on the lactate dehydrogenase, haemoglobin, reticulocyte and haptoglobin levels. Clinically relevant haemolysis was defined as a case requiring transfusion and\/or reintervention.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Clinically relevant haemolysis occurred in 6 of 282 patients (2.1%), with median age of 84 years. Three (50%) received a 20\u2009mm valve, and the oversizing ranged from \u22126.6% to +2.7%. All patients (100%) exhibited paravalvular leakage at the native commissural sites, with moderate or greater paravalvular leakage in two (33%). Lactate dehydrogenase levels exceeded 1200\u2009IU\/L in five (83%), four (67%) required transfusion and three (50%) underwent reintervention: balloon aortic valvuloplasty in one and valve-in-valve procedures in two. Haemolysis regressed in three reintervention cases; however, one patient died 9\u2009days postoperatively due to COVID-19. Among three patients (50%) managed conservatively, one developed prosthetic valve endocarditis, whereas another showed spontaneous regression of haemolysis. Over a median follow-up of 218 days, five patients (83%) survived.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Clinically relevant haemolysis occurred in 2.1% of patients undergoing TAVI with new-generation BEV, with 67% requiring transfusion and 50% undergoing reintervention. Further research is warranted to identify risk factors and optimise management strategies for haemolysis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2024-003112","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T12:00:17Z","timestamp":1736337617000},"page":"e003112","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Clinically relevant haemolysis after transcatheter aortic valve implantation with new-generation balloon-expandable valve"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-9922","authenticated-orcid":false,"given":"Ryosuke","family":"Higuchi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute, Fuchu, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Takamisawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute, Fuchu, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunobu","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute, Fuchu, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Nanasato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute, Fuchu, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Sakakibara Heart Institute, Fuchu, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"Isobe","sequence":"additional","affiliation":[{"name":"Sakakibara Heart Institute, Fuchu, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"2025081710590485000_12.1.e003112.1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/clc.23191","article-title":"Cardiac prostheses-related hemolytic anemia","volume":"42","author":"Alkhouli","year":"2019","journal-title":"Clin Cardiol"},{"key":"2025081710590485000_12.1.e003112.2","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.jacc.2021.03.295","article-title":"Mechanical Hemolysis Complicating Transcatheter Interventions for Valvular Heart Disease: JACC State-of-the-Art Review","volume":"77","author":"Cannata","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025081710590485000_12.1.e003112.3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.amjcard.2015.02.059","article-title":"Incidence and risk factors of hemolysis after transcatheter aortic valve implantation with a balloon-expandable valve","volume":"115","author":"Laflamme","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025081710590485000_12.1.e003112.4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2017.09.023","article-title":"Frequency and Significance of Intravascular Hemolysis Before and After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis","volume":"121","author":"Ko","year":"2018","journal-title":"Am J Cardiol"},{"key":"2025081710590485000_12.1.e003112.5","doi-asserted-by":"crossref","first-page":"F44","DOI":"10.1093\/eurheartj\/suaa098","article-title":"Intravascular haemolysis after transcatheter aortic valve implantation with self-expandable prosthesis: incidence, severity, and impact on long-term mortality","volume":"22","author":"\u0160ir\u00e1kov\u00e1","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"2025081710590485000_12.1.e003112.6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4244\/EIJ-D-23-00996","article-title":"Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry","volume":"20","author":"Yamamoto","year":"2024","journal-title":"EuroIntervention"},{"key":"2025081710590485000_12.1.e003112.7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjcard.2021.11.010","article-title":"Effect of Radiolucent Line-Guided Balloon-Expandable Transcatheter Aortic Valve Implantation on Subsequent Pacemaker Rate","volume":"165","author":"Ishizu","year":"2022","journal-title":"Am J Cardiol"},{"key":"2025081710590485000_12.1.e003112.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814052"},{"key":"2025081710590485000_12.1.e003112.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816885"},{"key":"2025081710590485000_12.1.e003112.10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.amjcard.2023.08.104","article-title":"Hemodynamics and Conduction Disturbance After Transcatheter Aortic Valve Implantation With SAPIEN3 Ultra Versus SAPIEN3: The HomoSAPIEN 2 Study","volume":"207","author":"Moriyama","year":"2023","journal-title":"Am J Cardiol"},{"key":"2025081710590485000_12.1.e003112.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395"},{"key":"2025081710590485000_12.1.e003112.12","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.4244\/EIJ-D-22-01110","article-title":"Percutaneous paravalvular leak closure after transcatheter aortic valve implantation: the international PLUGinTAVI Registry","volume":"19","author":"Flores-Umanzor","year":"2023","journal-title":"EuroIntervention"},{"key":"2025081710590485000_12.1.e003112.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2023.10.058","article-title":"Risk of Sinus Sequestration During Redo Transcatheter Aortic Valve Implantation: The Prevalence, Predictors, and Risk Stratification","volume":"211","author":"Higuchi","year":"2024","journal-title":"Am J Cardiol"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2024-003112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:59:14Z","timestamp":1755453554000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2024-003112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,8]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/openhrt-2024-003112"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2024-003112","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}